Search alternatives:
"caso open" » "case open" (Expand Search), "caso lopez" (Expand Search), "cases open" (Expand Search), "casdo open" (Expand Search), "casao open" (Expand Search), "caso opens" (Expand Search)
"do opens" » "do open" (Expand Search), "o opens" (Expand Search), "door opens" (Expand Search), "ddo opens" (Expand Search), "dao opens" (Expand Search), "do openss" (Expand Search)
"so opens" » "o opens" (Expand Search), "so open" (Expand Search), "who opens" (Expand Search), "sdo opens" (Expand Search), "sao opens" (Expand Search), "so openss" (Expand Search)
"o open" » "do open" (Expand Search), "ao open" (Expand Search), "o opens" (Expand Search)
"esmo open" » "esmdo open" (Expand Search), "esmao open" (Expand Search), "esmo opens" (Expand Search)
Showing 1 - 20 results of 1,034 for search '(((((("do opens") OR ("o open"))) OR ("esmo open"))) OR ((("so opens") OR ("caso open"))))', query time: 0.83s Refine Results
AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open
ESMO Open—Cancer Horizons and the future of oncology

CSCO joins ESMO Open—Cancer Horizons
ESMO Open: news in breast cancer 2019

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)
ESMO Open special series on new emerging targets in cancer immunotherapy

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment
One year of ESMO Open: Cancer Horizons—where are we going from here?

Plasmodesmata. A Not So Open-and-Shut Case
Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion
EDUCAÇÃO A DISTÂNCIA: O CASO OPEN UNIVERSITY

Desafios do Open Design
New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]
Adoção do Open Peer Review

How do Openers Contribute to Student Learning?
Criptografia digital: implementação do OpenPGP

Search Tools: Get RSS Feed — Email this Search — Save Search